Carmichael Roberts is a General Partner at North Bridge Venture Partners where he finances and builds companies that make new products using chemistry, materials science and/or materials engineering. He primarily focuses on very early stage ventures, including helping founders launch companies from initial formation. Carmichael led the North Bridge founding investment in 1366 technologies, Foro Energy and MC10. He also serves as the Lead Director in each of these companies.
Prior to joining North Bridge, Carmichael co-founded several companies including Arsenal Medical, 480 Biomedical, Surface Logix and Nano-Terra. He has served in an executive and/or chairman capacity for each of his companies.
Before starting his career as an entrepreneur, Carmichael worked in business development at GelTex Pharmaceuticals (acquired by Genzyme). Prior to GelTex, Carmichael was responsible for new product and business development at Sentry Products, a life science venture wholly owned by Union Carbide Corporation (acquired by Dow Chemical).
Carmichael is also very dedicated to developing medical products for developing nations. Along with Harvard University, Carmichael co-founded Diagnostics For All, Inc., a non-profit organization that is developing a materials platform to make low-cost diagnostics for poor and rural populations in developing nations. He currently serves as chairman of this organization.
Carmichael serves on the advisory boards for MIT’s Deshpande Center for Innovation, Harvard’s Nanoscale Science and Engineering Center, Duke’s School of Biomedical Engineering and the New England Clean Energy Council. In 1999, he was named by MIT’s Technology Review as one of the world’s top 100 young entrepreneurs. Carmichael is also a trustee of the Berklee College of Music, an overseer for the Boston Symphony Orchestra and a member of the Executive Committee for the Duke Alumni Association.
Carmichael received his B.S. and Ph.D. in organic chemistry from Duke University and was a national Science Foundation Fellow at Harvard University’s Departments of Chemistry and Chemical Biology. He also earned his M.B.A. from the MIT Sloan School of Management.